|
| 欧林生物(688319)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2025-07-07 | 22.47 | 0.06% | 40585.87 | 29.96 | 40540.93 | 99.82% | 股权激励限售股份 | | 2024-06-11 | 11718.36 | 28.90% | 40466.03 | 74.90 | 28822.57 | 71.10% | 首发原股东限售股份 | | 2023-06-19 | 14.43 | 0.04% | 28808.14 | 11718.36 | 28808.14 | 71.08% | 股权激励一般股份 | | 2023-06-08 | 202.65 | 0.50% | 28808.15 | 11718.36 | 28605.50 | 70.58% | 首发战略配售股份 | | 2022-06-08 | 25160.45 | 62.08% | 28605.49 | 11921.01 | 28605.49 | 70.58% | 首发原股东限售股份,首发战略配售股份 | | 2021-12-08 | 169.34 | 0.42% | 3891.07 | 36635.43 | 3891.07 | 9.60% | 首发机构配售股份 |
|